Obermatt

Carl Zeiss Meditec

GER:AFX · DE0005313704
Health Care Equipment & SuppliesLarge

360

50
EV / EBIT46
Price / Owner Earnings47
Owner Earnings Yield84
Dividend Yield45
Price/Sales78
EV / Gross Profit87
Price/Book84
Return on Capital45
Cash Return on Capital57
Return on Equity51
EBIT Margin44
Gross Profitability44
Cash Conversion83
Owner Earnings Margin61
Sales growth12
Profit Growth45
Long-Term EPS Growth45
Reinvestment42
Price momentum1
Debt load75
Refinancing92
Debt Payback31
Liquidity50
Analyst ratings9
Opinion Changes45
Price Target Upside38
Market mood65
Value Creation7/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Carl Zeiss Meditec clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryGermany
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeXTRA
Employees3,872
ISINDE0005313704
Last UpdateApr 2, 2026
Themes
Health DiagnosticsBiomedical EngineeringSurgeryEar Nose & Throat (ENT)NeurologyOphthalmologyIndustrialInformation TechnologyManufacturingMedicalMedical Device

Description

Carl Zeiss Meditec AG operates primarily in the medical technology sector. The company develops medical devices, solutions, and technologies that cater to healthcare professionals around the globe. The company specializes in areas such as ophthalmolo…

Analysis

Bargain bin

Carl Zeiss Meditec AG falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.

The price is fair. You pay 16.0× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 3% yearly growth; analysts expect 6%. The price, in other words, assumes less than the experts do.

The trajectory is tepid and the balance sheet is adequate. The company scores 7/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
58
2023202420252026

All-time high

83

Mar 2023

All-time low

21

Jan 2025

Average rank

57

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
78
61
42
22
Price/Earnings
46
39
32
19
Price/Book
84
70
29
36
Dividend Yield
45
63
59
51
Value (overall)
82
78
79
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Carl Zeiss Meditec with its peers
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
EssilorLuxottica
PAR:EL
55
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Alcon
VTX:ALC
51
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Smith & Nephew
LSE:SN.
86
CountryUK
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Medacta Group
SWX:MOVE
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Medartis Holding
SWX:MED
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →